Drugs / C2207
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06378684 | Sep → Dec 2023 | — | JW Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C2207 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06378684 ↗ |
| Route | Oral | “Tablet, Oral, QD for 10 Days, Washout period is more than 14 days after administration” NCT06378684 ↗ |